It takes two peroxisome proliferator-activated receptors (PPAR-β/δ and PPAR-γ) to tango idiopathic pulmonary fibrosis
Our data provide evidence that IPF patients may benefit from a combined activation of PPAR-β/δ and PPAR-γ.
Authors
- Barbara Ahlemeyer (ORCID: https://orcid.org/0009-0005-1278-8418)
- Vannuruswamy Garikapati (ORCID: https://orcid.org/0000-0003-1204-349X)
- Omelyan Trompak
- Eistine Boateng (ORCID: https://orcid.org/0000-0002-5450-5341)
- Clemens Ruppert (ORCID: https://orcid.org/0000-0002-0938-2469)
- Michael Seimetz (ORCID: https://orcid.org/0000-0002-1925-0240)
- Bernhard Spengler (ORCID: https://orcid.org/0000-0003-0179-5653)
- Rocio Bonilla-Martinez
- Srikanth Karnati (ORCID: https://orcid.org/0000-0001-9083-2916)
- Natalia El-Merhie (ORCID: https://orcid.org/0000-0002-0682-4022)
- Gani Oruqaj
- Mohammad Rashedul Alam
- Eveline Baumgart‐Vogt (ORCID: https://orcid.org/0000-0002-8265-3763)
- Andreas Günther (ORCID: https://orcid.org/0000-0002-2187-0975)
Institutions
- University of Toledo Medical Center (US)
- Justus-Liebig-Universität Gießen (DE)
- University of Würzburg (DE)
- Universities of Giessen and Marburg Lung Center (DE)
- Max Planck Institute of Molecular Cell Biology and Genetics (DE)
- University of Tübingen (DE)
- University of Toledo (US)
Publication Details
- Journal
- Respiratory Research
- Published
- 2024-09-23
- DOI
- https://doi.org/10.1186/s12931-024-02935-7
- Citations
- 7
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 2.93
Funders
- Justus Liebig Universität Gießen
- Deutscher Akademischer Austauschdienst